Guillaume Fond

Experience

• 2017–present
  Intervenant, Université Pierre et Marie Curie
• 2012–2016
  Enseignant-Chercheur associé, Université Paris-Est
• 2010–2012
  Chef de clinique-Enseignant, Université Montpellier 1

Education

• 2016 
  Congrès Français de psychiatrie, Prix de la meilleure publication scientifique
• 2016 
  European congress of NeuroPsychopharmacology, Award meilleur publication en psychiatrie- catégorie jeune chercheur
• 2011 
  Congrès de l'Encéphale- Paris, Prix du meilleur poster scientifique

Publications

• 2017
  Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set., European Archives of Psychiatry and clinical Neuroscience
• 2017
  Would I take antipsychotics, if I had psychotic symptoms? Examining determinants of the decision to take antipsychotics., Prog Neuropsychopharmacol Biol Psychiatry.
• 2017
  Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort., Psychiatry research
• 2017
  Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort., European Archives of Psychiatry and clinical Neuroscience
• 2017
  Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset., European Archives of Psychiatry and clinical Neuroscience
• 2016
  Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset., Journal of clinical Psychiatry
• 2016
  [Reflection on the psychiatric financial allocation in France]., Encephale
• 2016
  Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset., Schizophrenia Research
• 2016
  Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort., Schizophrenia Research
• 2016
  (Mis)use of Prescribed Stimulants in the Medical Student Community: Motives and Behaviors: A Population-Based Cross-Sectional Study., Medicine (Baltimore)
• 2016
  C-reactive protein as a differential biomarker of bipolar II depression versus major depressive disorder., World J Biol Psychiatry
• 2016
  Interleukin-1 β-targeted treatment strategies in inflammatory depression: toward personalized care., Acta Psychiatrica Scandinavica
• 2016
  Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia., Schizophrenia Research
• 2016
  Violent behavior and aggression in schizophrenia: Prevalence and risk factors. A multicentric study from three Latin-America countries., Schizophrenia Research
• 2016
  Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set., European Archives of Psychiatry and clinical Neuroscience
• 2016
  Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia., Schizophrenia Research
• 2016
  Medication and aggressiveness in "real world" schizophrenia: current issues and perspectives., Psychopharmacology (Berl)
• 2016
  Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset., Schizophrenia Bulle
• 2016
  Potentially inappropriate psychotropic prescription at discharge is associated with lower functioning in the elderly psychiatric inpatients. A cross-sectional study., Psychopharmacology (Berl)
• 2016
  Disparities in suicide mortality trends between United States of America and 25 European countries: retrospective analysis of WHO mortality database., Scientific Reports
• 2015
  Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia., Psychiatry research
• 2015
  The promise of biological markers for treatment response in first-episode psychosis: a systematic review., Schizophrenia Bulletin
• 2015
  A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap., European Psychiatry
• 2015
  Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia., Schizophrenia Research
• 2015
  Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study., Journal of Psychiatric Research
• 2015
  Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset., Psychopharmacology (Berl)
• 2015
  Ketamine vs other anesthetic agents for electroconvulsive therapy (ECT) in major depression., Journal of Psychiatric Research
• 2015
  Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review., Psychiatry research
• 2015
  Google Trends: Ready for real-time suicide prevention or just a Zeta-Jones effect? An exploratory study., Psychiatry research
• 2015
  Ketamine's effectiveness in unipolar versus bipolar depression., Psychopharmacology (Berl)
• 2015
  A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression., Scientific Reports
• 2015
  Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort., Schizophrenia Research
• 2015
  Pharmacoterrorism: the potential role of psychoactive drugs in the Paris and Tunisian attacks., Psychopharmacology (Berl)
• 2015
  [The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options]., La Presse Medicale
• 2015
  Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset., Psychopharmacology (Berl)
• 2015
  The World Health Organization (WHO) dataset for guiding suicide prevention policies: A 3-decade French national survey., Journal of affective disorders
• 2015
  Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set., Journal of affective disorders
• 2015
  Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis., Acta Psychiatrica Scandinavica
• 2015
  Do the treasures of 'big data' combined with behavioural intervention therapies contain the key to the mystery of large psychiatric issues?, Acta Psychiatrica Scandinavica
• 2015
  Ketamine administration in depressive disorders: a systematic review and meta-analysis., Psychopharmacology (Berl)
• 2014
  Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis., European Archives of Psychiatry and clinical Neuroscience
• 2014
  Fasting in mood disorders: neurobiology and effectiveness. A review of the literature., Psychiatry research
• 2014
  Nanopsychiatry--the potential role of nanotechnologies in the future of psychiatry: a systematic review., European NeuroPsychopharmacology
• 2014
  Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate., European Archives of Psychiatry and clinical Neuroscience
• 2014
  Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review., Acta Psychiatrica Scandinavica
• 2014
  D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis., Psychopharmacology (Berl)

Honours

Prix de la meilleure publication en psychiatrie, Congrès Français de Psychiatrie, 2016